Genome screen uncovers new targets for cancer immunotherapy

A new platform developed at Yale utilizes CRISPR technology to knock out genes individually and test which have the biggest impact on tumor response.
Source: Yale Science and Health News - Category: Universities & Medical Training Source Type: news